Literature DB >> 15919902

Complement activation is required for induction of a protective antibody response against West Nile virus infection.

Erin Mehlhop1, Kevin Whitby, Theodore Oliphant, Anantha Marri, Michael Engle, Michael S Diamond.   

Abstract

Infection with West Nile virus (WNV) causes a severe infection of the central nervous system (CNS) with higher levels of morbidity and mortality in the elderly and the immunocompromised. Experiments with mice have begun to define how the innate and adaptive immune responses function to limit infection. Here, we demonstrate that the complement system, a major component of innate immunity, controls WNV infection in vitro primarily in an antibody-dependent manner by neutralizing virus particles in solution and lysing WNV-infected cells. More decisively, mice that genetically lack the third component of complement or complement receptor 1 (CR1) and CR2 developed increased CNS virus burdens and were vulnerable to lethal infection at a low dose of WNV. Both C3-deficient and CR1- and CR2-deficient mice also had significant deficits in their humoral responses after infection with markedly reduced levels of specific anti-WNV immunoglobulin M (IgM) and IgG. Overall, these results suggest that complement controls WNV infection, in part through its ability to induce a protective antibody response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919902      PMCID: PMC1143684          DOI: 10.1128/JVI.79.12.7466-7477.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Characterization of neuronal cell death induced by complement activation.

Authors:  Y Shen; J A Halperin; L Benzaquen; C M Lee
Journal:  Brain Res Brain Res Protoc       Date:  1997-05

2.  Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.

Authors:  H Molina; V M Holers; B Li; Y Fung; S Mariathasan; J Goellner; J Strauss-Schoenberger; R W Karr; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

3.  The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.

Authors:  V A Bokisch; F H Top; P K Russell; F J Dixon; H J Müller-Eberhard
Journal:  N Engl J Med       Date:  1973-11-08       Impact factor: 91.245

4.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen.

Authors:  J M Ahearn; M B Fischer; D Croix; S Goerg; M Ma; J Xia; X Zhou; R G Howard; T L Rothstein; M C Carroll
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

5.  The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice.

Authors:  J T Hicks; F A Ennis; E Kim; M Verbonitz
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

6.  The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus.

Authors:  R L Hirsch; J A Winkelstein; D E Griffin
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

7.  Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.

Authors:  R O Ebanks; D E Isenman
Journal:  Mol Immunol       Date:  1996-02       Impact factor: 4.407

8.  West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice.

Authors:  D Ben-Nathan; I Huitinga; S Lustig; N van Rooijen; D Kobiler
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.

Authors:  M R Wessels; P Butko; M Ma; H B Warren; A L Lage; M C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

10.  Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis.

Authors:  D M Takefman; B L Sullivan; B E Sha; G T Spear
Journal:  Virology       Date:  1998-07-05       Impact factor: 3.616

View more
  88 in total

Review 1.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.

Authors:  David C Clark; Aaron C Brault; Elizabeth Hunsperger
Journal:  Arch Virol       Date:  2012-05-17       Impact factor: 2.574

2.  West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H.

Authors:  Kyung Min Chung; M Kathryn Liszewski; Grant Nybakken; Alan E Davis; R Reid Townsend; Daved H Fremont; John P Atkinson; Michael S Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-28       Impact factor: 11.205

Review 3.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.

Authors:  Ruchi Srivastava; Chandran Ramakrishna; Edouard Cantin
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

5.  Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner.

Authors:  Erin Mehlhop; Camilo Ansarah-Sobrinho; Syd Johnson; Michael Engle; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

6.  Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection.

Authors:  Christopher B Brooke; Alexandra Schäfer; Glenn K Matsushima; Laura J White; Robert E Johnston
Journal:  J Gen Virol       Date:  2011-12-28       Impact factor: 3.891

Review 7.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 9.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

10.  Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.

Authors:  Erin Mehlhop; Steevenson Nelson; Christiane A Jost; Sergey Gorlatov; Syd Johnson; Daved H Fremont; Michael S Diamond; Theodore C Pierson
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.